Parental distress may undermine treatment in children with recurrent brain tumors

NCT ID NCT07660458

Recruiting now Knowledge-focused Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether the emotional distress of parents—such as depression, anxiety, or trauma—affects how well children with recurrent medulloblastoma follow their treatment plans. Researchers will follow 450 parent-child pairs across four hospitals, measuring parental distress through questionnaires and tracking treatment adherence over 12 months. The goal is to identify which types of distress most strongly predict poor adherence, which could inform future support programs for families facing this devastating disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If parental distress is found to predict poor adherence, this could lead to targeted psychological support programs for caregivers, potentially improving treatment outcomes for children.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The results may not apply to all families, and other factors could influence adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEDULLOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

medulloblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MEDULLOBLASTOMA RECURRENT MEDULLOBLASTOMA

Contacts and locations

Locations

West China Hospital of Sichuan University
RECRUITING

Chengdu, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.